If you want to bank on the go, an app that's easy to navigate is important. Here are the best mobile banking apps and ...

The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...

Photoshop is renowned for image manipulation and raster-based imagery, ideal for composites and filters. Adobe Express is suitable for quick editing, social media content, and easy-to-use tools for ...

The Met Office has sent a warning to anyone with a mobile phone as parts of the UK continue to see some heavy rainfall over the weekend. A yellow weather warning for rain has been issued for ...

You might have heard speculation that electromagnetic radiation from mobile phones and wireless technologies is dangerous. The radio waves wireless technologies transmit are very weak. They do not ...

Creating an App – How to create a new app. User Guide – How to develop apps bootstrapped with Create React App. Create React App works on macOS, Windows, and Linux. If something doesn’t work, please ...

The Lloyds Bank app really was down today with many customers unable to use the banking service. Lloyds has told Express.co.uk the issues have now been fixed. "Our mobile app is back to normal," a ...

ABC announced that its mobile app will no longer be available on mobile devices and connected TVs as of Sept. 23. Despite this change, the network reassured viewers that they can still access all ...

Cigna division Express Scripts announced Friday that it's joining CVS Health subsidiary CVS Caremark in removing the rheumatoid arthritis treatment Humira from its major commercial formularies.

Express Scripts and UnitedHealth Group's Optum Rx - two of the largest PBMs - chose to keep Humira on their reimbursement lists for 2023 and 2024. Cigna in June made Humira biosimilars available ...

Now, Cigna’s Express Scripts is following suit in a move that could further chip away at Humira’s market share. Express Scripts, which is Cigna’s pharmacy benefit unit, is removing branded ...

Beginning in 2025, Express Scripts will favor biosimilars of Humira, including its own private-label version. Beginning in 2025, Express Scripts will remove Humira (adalimumab) from its commercial ...